Dianne Feinstein’s return to the U.S. Senate has been delayed by complications from shingles. The risk of contracting that debilitating disease can be sharply reduced with the Shingrix vaccine, made by GSK, which has its U.S. headquarters in Philadelphia.
But Feinstein’s office has declined to say whether she got the vaccine, citing privacy concerns.
The longtime senator, a Democrat from California, was hospitalized with shingles early in March. In an April 12 statement from her office, she said lingering symptoms had kept her from returning to the Senate.
